Innate Pharma SA Current Financial Liabilities
Innate Pharma SA (IPHYF) had Current Financial Liabilities of EUR 8.80 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:CurrentFinancialLiabilities · last filed 2026-04-01
- 2025-12-31: Current Financial Liabilities 8.80M EUR.
- 2025-06-30: Current Financial Liabilities 8.93M EUR.
- 2024-12-31: Current Financial Liabilities 8.71M EUR.
- 2024-06-30: Current Financial Liabilities 8.93M EUR.
| Period end | Current Financial Liabilities |
|---|---|
| 2025-12-31 | 8.80M EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 8.93M EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 8.71M EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 8.93M EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 8.94M EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 5.33M EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 2.10M EUR 20-F · filed 2025-04-30 |
| 2022-06-30 | 30.85M EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 30.75M EUR 20-F · filed 2024-04-04 |
| 2021-06-30 | 2.02M EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 2.14M EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 2.13M EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 1.35M EUR 20-F · filed 2021-04-27 |
| 2017-12-31 | 1.34M EUR 20-F · filed 2020-04-24 |